Eyegate制药

EYEG NASDAQ
0.1602
-0.0307
-16.08%
盘后: 0.1680 +0.0078 +4.87% 16:00 08/20 EDT
开盘
0.1850
昨收
0.1909
最高
0.1915
最低
0.1500
成交量
59.23万
成交均量(3M)
50.27万
52周最高
0.6400
52周最低
0.1500
换手率
1.30%
市值
731.73万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Eyegate制药 EYEG股票价格,Eyegate制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Eyegate Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company. The Company is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The Company's lead product, EGP-437, incorporates a reformulated topically active corticosteroid, dexamethasone phosphate, which is delivered into the ocular tissues through its drug delivery system, the EyeGate II Delivery System. The Company is developing EGP-437 for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and/or ciliary body, and macular edema, an abnormal thickening of the macula associated with the accumulation of excess fluids in the extracellular space of the neurosensory retina. The EyeGate II Delivery System is designed to deliver optimal quantities of drugs to the anterior or posterior segments of the eye.
展开 >

最近浏览

名称
价格
涨跌幅